Cargando…
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
Objective To evaluate the association between pioglitazone use and bladder cancer risk in patients with type 2 diabetes. Design Retrospective cohort study using propensity score matched cohorts. Settings Healthcare databases from Finland, the Netherlands, Sweden, and the United Kingdom. Data compris...
Autores principales: | Korhonen, Pasi, Heintjes, Edith M, Williams, Rachael, Hoti, Fabian, Christopher, Solomon, Majak, Maila, Kool-Houweling, Leanne, Strongman, Helen, Linder, Marie, Dolin, Paul, Bahmanyar, Shahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986836/ https://www.ncbi.nlm.nih.gov/pubmed/27530399 http://dx.doi.org/10.1136/bmj.i3903 |
Ejemplares similares
-
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2017) -
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2018) -
Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014) -
All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine
por: Strandberg, Arto Y., et al.
Publicado: (2016) -
Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study†
por: Haukka, Jari, et al.
Publicado: (2013)